|
Histamine H2 Receptor Antagonist Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- Merck Sharp & Dohme LLC1
Indications
- Malignant Neoplasm1
- Advanced Solid Tumors1
- Cancer1
San Antonio, Texas1 trial
A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
START San Antonio ( Site 0220)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.